CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-12 | White William Richard Director | Sale | −4,057 | $66.10 | $268K | 0 |
| 2023-12-12 | White William Richard Director | Option exercise · Stock Option (Right to Buy) | −21,084 | 7,024 | ||
| 2023-12-12 | White William Richard Director | Option exercise · Stock Option (Right to Buy) | −5,427 | 4,216 | ||
| 2023-12-12 | White William Richard Director | Option exercise · Stock Option (Right to Buy) | −7,000 | 0 | ||
| 2023-12-12 | Bryce Joanne Chief Financial Officer | Option exercise 10b5-1 | +2,500 | $2.65 | $7K | 5,000 |
| 2023-12-12 | Bryce Joanne Chief Financial Officer | Sale 10b5-1 | −2,500 | $65.22 | $163K | 2,500 |
| 2023-12-12 | Bryce Joanne Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 2,253 | ||
| 2023-12-12 | ORBIMED ADVISORS LLC Director | Sale | −14,400 | $60.16 | $866K | 1,182,425 |
| 2023-12-12 | ORBIMED ADVISORS LLC Director | Sale | −9,300 | $60.16 | $559K | 764,307 |
| 2023-12-12 | ORBIMED ADVISORS LLC Director | Sale | −3,600 | $60.16 | $217K | 295,605 |
| 2023-12-12 | Ashiya Mona Director | Sale | −14,400 | $60.16 | $866K | 1,182,425 |
| 2023-12-12 | Ashiya Mona Director | Sale | −9,300 | $60.16 | $559K | 764,307 |
| 2023-12-12 | Ashiya Mona Director | Sale | −3,600 | $60.16 | $217K | 295,605 |
| 2023-12-05 | Bryce Joanne Chief Financial Officer | Option exercise 10b5-1 | +526 | $1.01 | $531 | 4,286 |
| 2023-12-05 | Bryce Joanne Chief Financial Officer | Option exercise 10b5-1 | +755 | $1.01 | $763 | 5,041 |
| 2023-12-05 | Bryce Joanne Chief Financial Officer | Sale 10b5-1 | −1,148 | $55.29 | $63K | 3,893 |
| 2023-12-05 | Bryce Joanne Chief Financial Officer | Sale 10b5-1 | −1,293 | $56.55 | $73K | 2,600 |
| 2023-12-05 | Bryce Joanne Chief Financial Officer | Sale 10b5-1 | −100 | $57.06 | $6K | 2,500 |
| 2023-12-05 | Bryce Joanne Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −526 | 0 | ||
| 2023-12-05 | Bryce Joanne Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −755 | 752 |
Page 27 of 32 · 639 trades